Harms Reporting in Randomized Controlled Trials of Interventions Aimed at Modifying Microbiota
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Letters15 January 2019Harms Reporting in Randomized Controlled Trials of Interventions Aimed at Modifying MicrobiotaAïda Bafeta, PhD, Mitsuki Koh, MPH, Carolina Riveros, MSc, and Philippe Ravaud, MD, PhDAïda Bafeta, PhDINSERM U1153 and Université Paris Descartes-Sorbonne Paris Cité, Paris, France (A.B., C.R.)Search for more papers by this author, Mitsuki Koh, MPHColumbia University, New York, New York (M.K.)Search for more papers by this author, Carolina Riveros, MScINSERM U1153 and Université Paris Descartes-Sorbonne Paris Cité, Paris, France (A.B., C.R.)Search for more papers by this author, and Philippe Ravaud, MD, PhDINSERM U1153, Université Paris Descartes-Sorbonne Paris Cité, and French Cochrane Centre, Paris, France (P.R.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/L18-0562 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:We agree with Dr. Baldassarre that the regulatory model for approval of probiotics, prebiotics, and synbiotics could alter the evaluation of adverse events in randomized controlled trials, which may cause study publications to omit some safety data. This regulatory model has remained ambiguous and complex and varies by region (1, 2). Probiotics that have a long historical use or are used as additives or processing aids have been subject to few or no regulations. In contrast, those intended for new therapeutic purposes must follow a strict process for approval (3).We recognize that the safety and efficacy findings ...References1. von Wright A. Regulating the safety of probiotics—the European approach. Curr Pharm Des. 2005;11:17-23. [PMID: 15638749] CrossrefMedlineGoogle Scholar2. Sanders ME, Akkermans LM, Haller D, Hammerman C, Heimbach J, Hörmannsperger G, et al. Safety assessment of probiotics for human use. Gut Microbes. 2010;1:164-85. [PMID: 21327023] doi:10.4161/gmic.1.3.12127 CrossrefMedlineGoogle Scholar3. Doron S, Snydman DR. Risk and safety of probiotics. Clin Infect Dis. 2015;60 Suppl 2:S129-34. [PMID: 25922398] doi:10.1093/cid/civ085 CrossrefMedlineGoogle Scholar4. Ioannidis JP. Adverse events in randomized trials: neglected, restricted, distorted, and silenced [Editorial]. Arch Intern Med. 2009;169:1737-9. [PMID: 19858427] doi:10.1001/archinternmed.2009.313 CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: INSERM U1153 and Université Paris Descartes-Sorbonne Paris Cité, Paris, France (A.B., C.R.)Columbia University, New York, New York (M.K.)INSERM U1153, Université Paris Descartes-Sorbonne Paris Cité, and French Cochrane Centre, Paris, France (P.R.)Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M18-0343. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoHarms Reporting in Randomized Controlled Trials of Interventions Aimed at Modifying Microbiota Aïda Bafeta , Mitsuki Koh , Carolina Riveros , and Philippe Ravaud Harms Reporting in Randomized Controlled Trials of Interventions Aimed at Modifying Microbiota Maria Elisabetta Baldassarre Metrics Cited byGut microbiota - nutrition and healthUse of Probiotics for the Management of Acute Gastroenteritis in Children: An UpdateIntestinal Barrier Function–Non-alcoholic Fatty Liver Disease Interactions and Possible Role of Gut Microbiota 15 January 2019Volume 170, Issue 2Page: 143-144KeywordsAdverse eventsDecision makingDisclosurePrevention, policy, and public healthProbioticsPulsed-field gel electrophoresisResearch designSafetySafety studiesToxicology ePublished: 15 January 2019 Issue Published: 15 January 2019 Copyright & PermissionsCopyright © 2019 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Human Intestinal Microbiome in Health and Disease
Lynch, S. V., & Pedersen, O. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1600266 · Cited by 3,637
Besselink, M. G., van Santvoort, H. C., Buskens, E., Boermeester, M. A., van Goor, H., Timmerman, H. M., Nieuwenhuijs, V. B., Bollen, T. L., van Ramshorst, B., Witteman, B. J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60207-x · Cited by 1,367
Reducing waste from incomplete or unusable reports of biomedical research
Glasziou, P., Altman, D. G., Bossuyt, P., Boutron, I., Clarke, M., Julious, S., Michie, S., Moher, D., & Wager, E. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62228-x · Cited by 1,319
Doron, S., & Snydman, D. R. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ085 · Cited by 942
Safety assessment of probiotics for human use
Sanders, M. E., Akkermans, L. M. A., Haller, D., Hammerman, C., Heimbach, J. T., Hörmannsperger, G., & Huys, G. (2010) · Gut Microbes · doi:10.4161/gmic.1.3.12127 · Cited by 816
The role of the microbiome in human health and disease: An introduction for clinicians
Young, V. B. (2017) · BMJ · doi:10.1136/bmj.j831 · Cited by 527
A systematic review of the safety of probiotics
Didari, T., Solki, S., Mozaffari, S., Nikfar, S., & Abdollahi, M. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.872627 · Cited by 367
Reporting of Safety Results in Published Reports of Randomized Controlled Trials
(2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.306 · Cited by 287
Self-citationTiming and Completeness of Trial Results Posted at ClinicalTrials.gov and Published in Journals
Riveros, C., Dechartres, A., Perrodeau, E., Haneef, R., Boutron, I., & Ravaud, P. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001566 · Cited by 269
Self-citationMcFarland, L. V. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005047 · Cited by 235
Cited by
Swanson, K. S., Gibson, G. R., Hutkins, R., Reimer, R. A., Reid, G., Verbeke, K., Scott, K. P., Holscher, H. D., Azad, M. B., Delzenne, N. M., et al. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0344-2 · Cited by 2,196
Zmora, N., Zilberman-Schapira, G., Suez, J., Mor, U., Dori-Bachash, M., Bashiardes, S., Kotler, E., Zur, M., Regev-Lehavi, D., Brik, R. B.-Z., et al. (2018) · Cell · doi:10.1016/j.cell.2018.08.041 · Cited by 1,695
The pros, cons, and many unknowns of probiotics
Suez, J., Zmora, N., Segal, E., & Elinav, E. (2019) · Nature Medicine · doi:10.1038/s41591-019-0439-x · Cited by 1,398
Suez, J., Zmora, N., Zilberman-Schapira, G., Mor, U., Dori-Bachash, M., Bashiardes, S., Zur, M., Regev-Lehavi, D., Ben-Zeev Brik, R., Federici, S., et al. (2018) · Cell · doi:10.1016/j.cell.2018.08.047 · Cited by 1,184
Health Benefits of Heat-Killed (Tyndallized) Probiotics: An Overview
Piqué, N., Berlanga, M., & Miñana-Galbis, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102534 · Cited by 642
Metadata
- Authors
- Bafeta, A., Koh, M., Riveros, C., & Ravaud, P.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2019-01-15
- Volume
- 170
- Issue
- 2
- Pages
- 143-144
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2908845694
- Cited by
- 76
- References
- 14
- FWCI
- 10.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Harms Reporting in Randomized Controlled Trials of Interventions Aimed at Modifying Microbiota. https://app.cochat.ai/papers/10.7326/l18-0562
- The paper
- Bafeta, A., Koh, M., Riveros, C., & Ravaud, P. (2019). Harms Reporting in Randomized Controlled Trials of Interventions Aimed at Modifying Microbiota. Annals of Internal Medicine. https://doi.org/10.7326/l18-0562
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.